Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)
NCT ID: NCT01683500
Last Updated: 2015-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
4 participants
INTERVENTIONAL
2012-08-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Trial with medical device
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
NCT01429883
Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels
NCT01602653
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
NCT00720694
Extracorporeal Shock Wave Treatment for Cellulite
NCT01974115
Shockwave Phonophoresis on Calcaneal Spur Patients
NCT05373225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
shock wave therapy
intervention: shock wave therapy with Modulith SLK (Storz)
shock wave therapy with Modulith SLK (Storz)
Three sessions with shock wave therapy, interval of one week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
shock wave therapy with Modulith SLK (Storz)
Three sessions with shock wave therapy, interval of one week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Calcinosis cutis due to connective tissue disease
* information about ESWT given
* Patient understands the study and signs the informed consent
Exclusion Criteria
* cuagulopathy
* sepsis
* pregnancy
* pace maker
* severe disease in the opinion of the investigator
* cardiac risk with NYHA III-IV
* Ehlers-Danlos-Syndrome
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra Blumhardt, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Rheumatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Division of Rheumatology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCESWT01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.